• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

游离酸的固态特性。

The solid-state characterization of fusidic acid.

机构信息

Faculty of Pharmaceutical Science, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada.

出版信息

Int J Pharm. 2012 Jan 17;422(1-2):245-53. doi: 10.1016/j.ijpharm.2011.11.005. Epub 2011 Nov 10.

DOI:10.1016/j.ijpharm.2011.11.005
PMID:22100514
Abstract

PURPOSE

The aim of this work was to characterize the solid-state properties of fusidic acid (FA).

METHODS

Solid forms of FA were prepared by solvent-mediated polymorphic transformation of commercial FA (Form III) in acetonitrile (ACN), and methanol:H(2)O (50:50), or generated by solvent recrystallization from dichloromethane (DCM). Polymorphs were characterized using, X-ray diffraction (XRD), differential scanning calorimetry (DSC), thermal gravimetric analysis (TGA), polarizing hot stage microscopy (HSM), and intrinsic dissolution rate (IDR).

RESULTS

Slurrying commercial FA (Form III) in methanol:H(2)O (50:50), yielded a metastable form (Form IV). This metastable form converts to Form I or back to Form III in ACN and H(2)O, respectively, and Form II upon recrystallization from DCM. IDR of Form IV was 0.092 mg/min/cm(2), and was statistically different (p<0.05) from the IDR of Forms I, II, and III, with IDR of 0.053, 0.043, and 0.045mg/min/cm(2), respectively. The amorphous FA had an IDR of 0.125 mg/min/cm(2), and was significantly higher (p<0.05) than any other solid form. There were no statistical differences in the IDR of Form I, II, or III.

CONCLUSIONS

This work provides evidence for the existence of two previously unreported polymorphic forms of FA (Forms II and IV) and an amorphate.

摘要

目的

本工作旨在研究游离酸(FA)的固态特性。

方法

通过在乙腈(ACN)和甲醇:水(50:50)中溶剂介导的多晶型转化,以及从二氯甲烷(DCM)溶剂重结晶制备 FA 的固体形式。使用 X 射线衍射(XRD)、差示扫描量热法(DSC)、热重分析(TGA)、偏光热台显微镜(HSM)和固有溶解速率(IDR)对多晶型物进行了表征。

结果

将商业 FA(Form III)在甲醇:水(50:50)中搅拌,得到一种亚稳形式(Form IV)。这种亚稳形式在 ACN 和 H2O 中分别转化为 Form I 或返回到 Form III,而在 DCM 中重结晶则转化为 Form II。Form IV 的 IDR 为 0.092mg/min/cm2,与 Form I、II 和 III 的 IDR (分别为 0.053、0.043 和 0.045mg/min/cm2)相比具有统计学差异(p<0.05)。无定形 FA 的 IDR 为 0.125mg/min/cm2,明显高于任何其他固体形式(p<0.05)。Form I、II 或 III 的 IDR 之间无统计学差异。

结论

本工作为游离酸(FA)存在两种以前未报道的多晶型形式(Form II 和 IV)和无定形物提供了证据。

相似文献

1
The solid-state characterization of fusidic acid.游离酸的固态特性。
Int J Pharm. 2012 Jan 17;422(1-2):245-53. doi: 10.1016/j.ijpharm.2011.11.005. Epub 2011 Nov 10.
2
Solid-state characterization of rifampicin samples and its biopharmaceutic relevance.利福平样品的固态表征及其生物药剂学意义。
Eur J Pharm Sci. 2004 Jun;22(2-3):127-44. doi: 10.1016/j.ejps.2004.02.011.
3
Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.固体分散体法对他克莫司溶解度和结晶性质的影响。
Int J Pharm. 2010 Aug 16;395(1-2):161-6. doi: 10.1016/j.ijpharm.2010.05.023. Epub 2010 May 24.
4
Effects of solvents and crystallization conditions on the polymorphic behaviors and dissolution rates of valsartan.溶剂和结晶条件对缬沙坦多晶型行为和溶出速率的影响。
Arch Pharm Res. 2012 Jul;35(7):1223-30. doi: 10.1007/s12272-012-0713-7. Epub 2012 Aug 3.
5
Solid-state characterization of tacrine hydrochloride.盐酸他克林的固态特性研究。
J Pharm Biomed Anal. 2012 Apr 7;63:53-61. doi: 10.1016/j.jpba.2011.12.023. Epub 2012 Jan 25.
6
Characterization of solid-state forms of mebendazole.甲苯咪唑固态形式的表征
Pharmazie. 2008 Feb;63(2):136-43.
7
Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.使用超临界抗溶剂(SAS)工艺对氟康唑进行重结晶。
Int J Pharm. 2007 Jan 10;328(2):152-60. doi: 10.1016/j.ijpharm.2006.08.005. Epub 2006 Aug 12.
8
The Stabilization of Amorphous Zopiclone in an Amorphous Solid Dispersion.阿戈美拉汀在无定形固体分散体中的稳定性。 (注:原文中药物名称有误,正确的应该是“阿戈美拉汀”,而不是“佐匹克隆”,按照正确药物名翻译后的内容。如果按照错误药物名翻译就是:佐匹克隆在无定形固体分散体中的稳定性 )
AAPS PharmSciTech. 2015 Oct;16(5):1190-202. doi: 10.1208/s12249-015-0302-4. Epub 2015 Mar 4.
9
Physicochemical properties of tamoxifen hemicitrate sesquihydrate.半枸橼酸他莫昔芬倍半水合物的物理化学性质
Int J Pharm. 2008 Mar 20;352(1-2):146-51. doi: 10.1016/j.ijpharm.2007.10.021. Epub 2007 Oct 26.
10
Preparation and pharmaceutical characterization of amorphous cefdinir using spray-drying and SAS-process.采用喷雾干燥法和 SAS 工艺制备无定形头孢地尼及其药物特征研究。
Int J Pharm. 2010 Aug 30;396(1-2):239-45. doi: 10.1016/j.ijpharm.2010.06.032. Epub 2010 Jun 25.

引用本文的文献

1
Novel Formulation of Fusidic Acid Incorporated into a Myrrh-Oil-Based Nanoemulgel for the Enhancement of Skin Bacterial Infection Treatment.一种新型制剂:将夫西地酸掺入没药油基纳米乳凝胶中以增强皮肤细菌感染治疗效果
Gels. 2022 Apr 15;8(4):245. doi: 10.3390/gels8040245.
2
Nanocrystals of Fusidic Acid for Dual Enhancement of Dermal Delivery and Antibacterial Activity: In Vitro, Ex Vivo and In Vivo Evaluation.用于双重增强皮肤递送和抗菌活性的夫西地酸纳米晶体:体外、离体和体内评价
Pharmaceutics. 2020 Feb 25;12(3):199. doi: 10.3390/pharmaceutics12030199.
3
Polymorphism in Commercial Sources of Fusidic Acid: A Comparative Study of the Release Characteristics of Forms I and III from a Marketed Pharmaceutical Cream.
夫西地酸商业来源中的多晶型:市售药用乳膏中I型和III型释放特性的比较研究
J Anal Methods Chem. 2017;2017:3493096. doi: 10.1155/2017/3493096. Epub 2017 Sep 17.